Palantir Technologies Inc. - Class A Common Stock (PLTR)
135.91
-10.12 (-6.93%)
NASDAQ · Last Trade: May 5th, 7:25 PM EDT
Detailed Quote
Previous Close
146.03
Open
140.30
Bid
135.14
Ask
135.23
Day's Range
134.72 - 142.98
52 Week Range
105.32 - 207.52
Volume
89,555,733
Market Cap
275.55B
PE Ratio (TTM)
219.21
EPS (TTM)
0.6
Dividend & Yield
N/A (N/A)
1 Month Average Volume
47,357,140
Chart
About Palantir Technologies Inc. - Class A Common Stock (PLTR)
Palantir Technologies is a public software company that specializes in big data analytics and provides platforms for organizations to integrate, visualize, and analyze large amounts of data from disparate sources. Its flagship products, Palantir Gotham and Palantir Foundry, are designed to assist government agencies and commercial enterprises in making data-driven decisions by offering advanced analytical capabilities, collaborative tools, and visualization features. The company has gained prominence for its work with intelligence and defense organizations, as well as its growing presence in various industries such as finance, healthcare, and manufacturing, enabling clients to derive actionable insights and enhance their operational efficiency. Read More
Financial technology provider Jack Henry & Associates (NASDAQ:JKHY) announced better-than-expected revenue in Q1 CY2026, with sales up 10.6% year on year to ...
Health and wellness products company USANA Health Sciences (NYSE:USNA) reported Q1 CY2026 results topping the market’s revenue expectations, but sales were f...
Business development company Sixth Street Specialty Lending (NYSE:TSLX) missed Wall Street’s revenue expectations in Q1 CY2026, with sales falling 19.7% year...
Auto financing company Credit Acceptance (NASDAQ:CACC) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 44.8% year on ye...
What Happened? Shares of data analytics company Palantir Technologies (NASDAQ:PLTR) fell 6.6% in the afternoon session after it reported first-quarter result...
What Happened? Shares of ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ:OCUL) fell 5.8% in the afternoon session after the company report...
What Happened? Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 20.3% in the morning session after it reported first-quarter 2026 re...
